Cargando…
Compound Kushen Injection Induces Immediate Hypersensitivity Reaction Through Promoting the Production of Platelet-Activating Factor via de Novo Pathway
Compound Kushen Injection (CKI) is a bis-herbal formulation extracted from Kushen (Radix Sophorae Flavescentis) and Baituling (Rhizoma Heterosmilacis Yunnanensis). Clinically, it is used as the adjuvant treatment of cancer. However, with the increased application, the cases of immediate hypersensiti...
Autores principales: | Gao, Yuan, Hai, Lina, Kang, Yuan, Qin, Wenjie, Liu, Fang, Cai, Runlan, Yang, Xiuwei, Qi, Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531113/ https://www.ncbi.nlm.nih.gov/pubmed/34690789 http://dx.doi.org/10.3389/fphar.2021.768643 |
Ejemplares similares
-
Qing-Kai-Ling Injection Induces Immediate Hypersensitivity Reaction via the Activation of Anaphylatoxin C3
por: Gao, Yuan, et al.
Publicado: (2020) -
A System Pharmacology Model for Decoding the Synergistic Mechanisms of Compound Kushen Injection in Treating Breast Cancer
por: Li, Yi, et al.
Publicado: (2021) -
Compound Kushen Injection Protects Skin From Radiation Injury via Regulating Bim
por: Zheng, Jianxiao, et al.
Publicado: (2021) -
Shuang-Huang-Lian injection induces an immediate hypersensitivity reaction via C5a but not IgE
por: Gao, Yuan, et al.
Publicado: (2018) -
Evaluation of efficacy and safety for compound kushen injection combined with intraperitoneal chemotherapy for patients with malignant ascites: A systematic review and meta-analysis
por: Yu, Hui-Bo, et al.
Publicado: (2023)